Retrophin (RTRX) declines as the late-stage study on a rare neurological disorder candidate failed to achieve its main goal.
source https://finance.yahoo.com/news/retrophin-down-neurological-disorder-drug-113811422.html?.tsrc=rss
Retrophin (RTRX) declines as the late-stage study on a rare neurological disorder candidate failed to achieve its main goal.
source https://finance.yahoo.com/news/retrophin-down-neurological-disorder-drug-113811422.html?.tsrc=rss
blaineonline.finance.blog 